Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

System for integrated adherence monitoring: real-time non-adherence risk assessment in pediatric kidney transplantation.

Pai AL, Rausch J, Tackett A, Marsolo K, Drotar D, Goebel J.

Pediatr Transplant. 2012 Jun;16(4):329-34. doi: 10.1111/j.1399-3046.2012.01657.x.

PMID:
22353189
2.

Non-adherence and graft failure in adult liver transplant recipients.

Lieber SR, Volk ML.

Dig Dis Sci. 2013 Mar;58(3):824-34. doi: 10.1007/s10620-012-2412-0.

PMID:
23053889
3.

Medication adherence in pediatric and adolescent liver transplant recipients.

Shemesh E, Shneider BL, Savitzky JK, Arnott L, Gondolesi GE, Krieger NR, Kerkar N, Magid MS, Stuber ML, Schmeidler J, Yehuda R, Emre S.

Pediatrics. 2004 Apr;113(4):825-32.

PMID:
15060234
4.

Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation.

Lo A, Egidi MF, Gaber LW, Shokouh-Amiri MH, Nazakatgoo N, Fisher JS, Gaber AO.

Clin Transplant. 2004 Feb;18(1):53-61.

PMID:
15108771
5.

Medication adherence in the transition of adolescent kidney transplant recipients to the adult care.

Akchurin OM, Melamed ML, Hashim BL, Kaskel FJ, Del Rio M.

Pediatr Transplant. 2014 Aug;18(5):538-48. doi: 10.1111/petr.12289.

6.

Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure.

Filler G, Womiloju T, Feber J, Lepage N, Christians U.

Am J Transplant. 2005 Aug;5(8):2005-10.

7.

Clinical consequences of non adherence to immunosuppressive medication in kidney transplant patients.

Denhaerynck K, Burkhalter F, Schäfer-Keller P, Steiger J, Bock A, De Geest S.

Transpl Int. 2009 Apr;22(4):441-6. doi: 10.1111/j.1432-2277.2008.00820.x.

8.

An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.

Venkat VL, Nick TG, Wang Y, Bucuvalas JC.

Pediatr Transplant. 2008 Feb;12(1):67-72. doi: 10.1111/j.1399-3046.2007.00794.x.

PMID:
18186891
9.

Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus.

Ortega Suárez FJ, Sánchez Plumed J, Pérez Valentín MA, Pereira Palomo P, Muñoz Cepeda MA, Lorenzo Aguiar D; Grupo de Estudio Vatren..

Nefrologia. 2011;31(6):690-6. doi: 10.3265/Nefrologia.pre2011.Aug.10973. English, Spanish.

10.

Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.

Sampson VB, Dunn SP, Rymeski B, Malatack J, Rong NH, Flynn L, Krueger LJ.

J Pediatr Surg. 2008 Jun;43(6):1134-41. doi: 10.1016/j.jpedsurg.2008.02.044.

PMID:
18558196
11.

Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients.

Chan L, Hartmann E, Cibrik D, Cooper M, Shaw LM.

Transplantation. 2010 Jul 15;90(1):31-7. doi: 10.1097/TP.0b013e3181de1d67.

PMID:
20517177
12.

Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation.

Hsiau M, Fernandez HE, Gjertson D, Ettenger RB, Tsai EW.

Transplantation. 2011 Oct 27;92(8):918-22. doi: 10.1097/TP.0b013e31822dc34f.

PMID:
21857278
13.

Measuring adherence to medications: are complex methods superior to simple ones?

Shemesh E.

Pediatr Transplant. 2012 Jun;16(4):315-7. doi: 10.1111/j.1399-3046.2012.01676.x. No abstract available.

PMID:
22452614
14.

Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients.

El-Sabrout R, Weiss R, Butt F, Delaney V, Qadir M, Hanson P, Butt K.

Transplant Proc. 2002 Aug;34(5):1942-3. No abstract available.

PMID:
12176636
15.

Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.

Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF; Sirolimus High-Risk Study Group..

Transplantation. 2008 Nov 15;86(9):1187-95. doi: 10.1097/TP.0b013e318187bab0.

PMID:
19005398
16.

Adherence to Immunosuppressive Medication in Renal Transplant Recipients From Follow-up Outpatient in China: Association of 2 Different Measurement Methods.

Liu J, Liu S, Yan J, Yi Q, Huang H.

Clin Ther. 2015 Nov 1;37(11):2572-80. doi: 10.1016/j.clinthera.2015.09.014.

PMID:
26519232
17.

Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.

Zhao W, Fakhoury M, Baudouin V, Maisin A, Deschênes G, Jacqz-Aigrain E.

Ther Drug Monit. 2011 Dec;33(6):681-7. doi: 10.1097/FTD.0b013e318235d067.

PMID:
22011724
18.

Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal.

Heilman RL, Cortese C, Geiger XJ, Younan K, Wadei HM, Mai ML, Reddy KS, Gonwa TA.

Transplantation. 2012 Jan 15;93(1):47-53. doi: 10.1097/TP.0b013e3182394cb3.

PMID:
22067270
19.

Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children.

Pollock-Barziv SM, Finkelstein Y, Manlhiot C, Dipchand AI, Hebert D, Ng VL, Solomon M, McCrindle BW, Grant D.

Pediatr Transplant. 2010 Dec;14(8):968-75. doi: 10.1111/j.1399-3046.2010.01409.x.

PMID:
21040278
20.

Adherence to immunosuppression in adult lung transplant recipients: prevalence and risk factors.

Bosma OH, Vermeulen KM, Verschuuren EA, Erasmus ME, van der Bij W.

J Heart Lung Transplant. 2011 Nov;30(11):1275-80. doi: 10.1016/j.healun.2011.05.007.

PMID:
21724418
Items per page

Supplemental Content

Support Center